RankingsPricing
  1. JP-listed companies
  2. AFC-HD AMS Life Science Co.,Ltd.
  3. Financials
  4. Revenue

AFC-HD AMS Life Science Co.,Ltd.JP:2927

Market cap
¥12.4B
P/E ratio
8.3x
SummaryFinancialsHistorySegmentsOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Aug 31, 202532,655+8.18%
Aug 31, 202430,185+18.01%
Aug 31, 202325,579+11.23%
Aug 31, 202222,997+2.81%
Aug 31, 202122,368+41.40%
Aug 31, 202015,819-2.67%
Aug 31, 201916,253+2.89%
Aug 31, 201815,796+4.32%
Aug 31, 201715,142+3.49%
Aug 31, 201614,631+1.50%
Aug 31, 201514,415+5.01%
Aug 31, 201413,728-4.44%
Aug 31, 201314,366-2.90%
Aug 31, 201214,795+0.96%
Aug 31, 201114,654

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)